肾脏去神经术综述
本综述聚焦难治性高血压的非药物器械治疗,介绍肾脏去神经术的降压机制、射频/超声/神经毁损剂三种技术路径,汇总近期对照试验在多种高血压人群中的疗效与安全性,并讨论患者选择优化等挑战。
要点
- 约2/5的难治性高血压患者存在用药不依从。
- 肾脏去神经术有射频、超声、肾周组织注射神经毁损剂三种路径。
- 患者选择优化是该领域当前面临的挑战之一。
核心结论
- 肾脏去神经术可能作为标准降压治疗的补充手段。
- 患者选择优化是该领域面临的挑战之一。
- 该领域快速发展,近期值得期待。
研究设计与样本
- 综述,检索并汇总近期对照试验在多种高血压人群中的疗效与安全性数据。
主要发现
- 约2/5的难治性高血压患者存在用药不依从。
- 至少3种肾脏去神经术路径在研究中:射频能量、超声、向肾周血管组织注射神经毁损剂。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Uncontrolled hypertension persists as an important health issue despite the availability of many medications and nondrug therapies that lower blood pressure. Increasingly, nonadherence to medication is found in approximately 2 of every 5 patients with uncontrolled hypertension. In the search for interventions that lower blood pressure that do not rely on adherence to a regimen requiring daily ingestion of medication or repeated physical activity, device-based methods that denervate the renal arteries have emerged as a potential complement to standard antihypertensive treatments. At least 3 different approaches to renal artery denervation are under active investigation, including the use of radiofrequency energy, ultrasound, or the injection of neurolytic agents into the renal perivascular tissue. In this review, we cover what is currently known about the mechanisms of antihypertensive effects of renal denervation, summarize the efficacy and safety of renal denervation using recent controlled trial publications in a number of hypertensive populations, and conclude with some thoughts about challenges in the field, including the optimization of patient selection for the procedure and what the reader can expect in the near future in this rapidly developing field.
引用
- Rey-García J, Townsend RR. Renal Denervation: A Review. Am J Kidney Dis. 2022. PMID: 35598810. doi:10.1053/j.ajkd.2022.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。